Searched for
SERUM INSTITUTE CEO
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- IPL may become the GOAT of sports world; League sees sharp rise in valuations on record media rights deals, deep-pocketed sponsorsIPL franchise values are soaring, projected to hit $15 billion by 2032. This growth rivals top European football clubs. Record media rights...
- ET Awards for Corporate Excellence 2025: Celebrating India Inc. distinguished iconsThe ET Awards for Corporate Excellence 2025 honour 10 outstanding achievers, from policy reformers and business leaders to emerging compani...
- Rajasthan Royals sold for $1.65B to Mittal-Poonawalla consortiumA consortium led by the Mittal family and including Adar Poonawalla will acquire Rajasthan Royals for $1.65 billion. The Mittal family will...
- ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
- Serum Institute says working to develop Monkeypox vaccineThe World Health Organisation on August 14 declared the Mpox outbreak a public health emergency of international concern. The move came aft...
- Adar Poonawalla to buy London property for Rs 1,440 crore, the second-most expensive ever soldIndian billionaire Adar Poonawalla is set to purchase a London mansion, Aberconway House, for £138 million (Rs 1,440 crore), marking the ci...
- Serum Institute CEO Adar Poonawalla expects malaria vaccine supply-demand mismatch to end in 2024"We're expecting a final WHO approval in the coming months, after which we can roll it out," Poonawalla told Reuters in an interview, addin...
- Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year, says Adar PoonawallaPoonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.Speaking to after the meeting, the...
- Oxford University to get Poonawala vaccine research facility; to get GBP 50 million fundingSerum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed ...
- Serum Institute CEO Poonawalla apprises Home Minister about COVID-19 vaccine rolloutApart from making efforts to meet the requirements of India, SII, the world's largest vaccine maker, is also trying its best to balance the...
- Antonio Guterres saddened by loss of life in fire at Serum Institute: UN spokespersonFive men died after a fire broke out in a five-storeyed under-construction building in the Serum Institute of India's Manjari premises in P...
- Serum Institute fire: Rahul Gandhi urges state govt to provide necessary help to victims, kinFive persons died and nine were evacuated from a building in the Serum Institute of India's Manjari premises in Pune after a fire broke out...
- Govt panel recommends marketing authorisation to Serum Institute’s Covishield vaccine"The Subject Expert Committee has recommended in favour of marketing authoritsation to SII’s vaccine but with certain conditions, a person ...
- India considering accelerated review of Covid-19 vaccine emergency use: Govt official"We are in the process of reviewing. It is an accelerated reviewing process, which is there for Serum too," the government official said. "...
- AstraZeneca vaccine results a shot in the arm for IndiaThe AstraZeneca shot is one of India’s best hopes for an early vaccine. Unlike Pfizer and Moderna’s jab that have shown encouraging results...
- Serum Institute to launch Dengue Monoclonal in India in next two yearsScientific details of the vaccines remained unclear. However, the vaccine maker said it will begin registrations for the vaccine soon.
- Pune firm set to roll out cure for dengueSerum Institute will develop a drug to treat all 4 strains of dengue, and is in the process of applying for a 'speedy approval' to roll-out...
- Cipla Ltd to market Serum Institute's paediatric vaccines in EuropeCipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.
- NeuClone to collaborate with Serum Institute of India; to supply drugs globallyNeuClone has retained licence to the jointly developed biosimilars for the developed markets of USA, Europe, Canada, Australia, Taiwan.
Load More
